glp 1 drugs and breast cancer GLP-1 May Improve Survival for Some Patients GLP-1 Drugs and Breast Cancer:
Description
GLP-1RAs act on several of these mechanisms
The risk of bias assessment indicated that all studies had a low risk of bias
Each has different ingredient profiles and varying levels of evidence
doi: 10.1093/brain/awaa262
doi: 10.1093/eurheartj/ehad192
Promising Results: Early trials showed promising weight loss results, with participants losing an average of 5-13% of their body weight after taking Danuglipron for several months
